212 related articles for article (PubMed ID: 15543525)
1. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
[TBL] [Abstract][Full Text] [Related]
2. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.
Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ
J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113
[TBL] [Abstract][Full Text] [Related]
3. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
[TBL] [Abstract][Full Text] [Related]
4. Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport.
Xiong F; Xiao S; Yu M; Li W; Zheng H; Shang Y; Peng F; Zhao C; Zhou W; Chen H; Fang L; Chamberlain JS; Zhang C
BMC Neurosci; 2007 Jul; 8():50. PubMed ID: 17617925
[TBL] [Abstract][Full Text] [Related]
5. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22.
Dilber MS; Phelan A; Aints A; Mohamed AJ; Elliott G; Smith CI; O'Hare P
Gene Ther; 1999 Jan; 6(1):12-21. PubMed ID: 10341871
[TBL] [Abstract][Full Text] [Related]
6. Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivo.
Zavaglia D; Lin EH; Guidetti M; Pluquet O; Hainaut P; Favrot MC; Coll JL
J Gene Med; 2005 Jul; 7(7):936-44. PubMed ID: 15754307
[TBL] [Abstract][Full Text] [Related]
7. [Tegument viral protein 22 enhanced cell-killing effect of the herpes simplex virus thymidine kinase/ganciclovir system on ovarian cancer in vivo].
Kong BH; Wang WX; Liu CS; Ma DX; Qu X
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):195-8. PubMed ID: 12885362
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death.
Roeder GE; Parish JL; Stern PL; Gaston K
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):157-65. PubMed ID: 14709162
[TBL] [Abstract][Full Text] [Related]
9. Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase.
Roy V; Qiao J; de Campos-Lima P; Caruso M
Gene Ther; 2005 Jan; 12(2):169-76. PubMed ID: 15483667
[TBL] [Abstract][Full Text] [Related]
10. Intercellular spread of GFP-VP22.
Aints A; Dilber MS; Smith CI
J Gene Med; 1999; 1(4):275-9. PubMed ID: 10738560
[TBL] [Abstract][Full Text] [Related]
11. Fusion of herpes simplex virus thymidine kinase to VP22 does not result in intercellular trafficking of the protein.
Beerens AM; Rots MG; de Vries EF; Haisma HJ
Int J Mol Med; 2007 May; 19(5):841-9. PubMed ID: 17390091
[TBL] [Abstract][Full Text] [Related]
12. Quantification of VP22-GFP spread by direct fluorescence in 15 commonly used cell lines.
Wybranietz WA; Prinz F; Spiegel M; Schenk A; Bitzer M; Gregor M; Lauer UM
J Gene Med; 1999; 1(4):265-74. PubMed ID: 10738559
[TBL] [Abstract][Full Text] [Related]
13. Enhanced effect of myocardial gene transfection by VP22-mediated intercellular protein transport.
Suzuki K; Murtuza B; Brand NJ; Varela-Carver A; Fukushima S; Yacoub MH
J Mol Cell Cardiol; 2004 Apr; 36(4):603-6. PubMed ID: 15081320
[TBL] [Abstract][Full Text] [Related]
14. VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo.
Zender L; Kühnel F; Köck R; Manns M; Kubicka S
Cancer Gene Ther; 2002 Jun; 9(6):489-96. PubMed ID: 12032659
[TBL] [Abstract][Full Text] [Related]
15. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
[TBL] [Abstract][Full Text] [Related]
16. Intercellular trafficking of VP22-GFP fusion proteins.
Elliott G; O'Hare P
Gene Ther; 1999 Jan; 6(1):149-51. PubMed ID: 10341888
[TBL] [Abstract][Full Text] [Related]
17. Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein.
Zavaglia D; Favrot MC; Eymin B; Tenaud C; Coll JL
Gene Ther; 2003 Feb; 10(4):314-25. PubMed ID: 12595890
[TBL] [Abstract][Full Text] [Related]
18. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
[TBL] [Abstract][Full Text] [Related]
19. Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting.
Aints A; Güven H; Gahrton G; Smith CI; Dilber MS
Gene Ther; 2001 Jul; 8(14):1051-6. PubMed ID: 11526452
[TBL] [Abstract][Full Text] [Related]
20. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells.
Fang B; Xu B; Koch P; Roth JA
Gene Ther; 1998 Oct; 5(10):1420-4. PubMed ID: 9930348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
